Skip to main content
. 2013 Dec 23;10:360. doi: 10.1186/1743-422X-10-360

Table 2.

# of subjects in each population positive for both anti-HERV K10 Gag & Pol antibodies

Population N # positive (%)
VBD*
100
0(0)
LGLL*
53
0(0)
HTLVt*
74
18(24)
HTLVm*+
16
14(88)
HTLVn*+
58
4(7)
MS*+ 83 4(5)

*p = 1.000, < 0.001, < 0.001, 0.017 and 0.041 for VBD vs LGLL, HTLVt, HTLVm; HTLVn; and MS, respectively.

+p = < 0.001 for HTLVm vs HTLVn or vs MS.